A Prospective Clinical Evaluation of the Centinel Spine™ STALIF C® No Profile® Integrated Interbody Fusion™ Device
This is a post-market analysis study of FDA-approved cervical fusion devices: The STALIF C, and STALIF C-Ti. The purpose of this study is to collect information about how well different types of patients do after spinal fusion, based on their earlier treatments (conservative therapy). Spinal fusion is recognized as the standard treatment for patients with Degenerative Disc Disease (DDD) that have failed conservative therapy. It is not clear which patients will do well with conservative therapy and which patients will not. Further, it is not fully understood which patients will do best with spinal fusion. This study is designed to better understand the links between conservative care, spinal fusion and patient outcomes. Patients’ participation in this study involves the collection of data associated with standard of care procedures and follow-up. It does not involve anything special in regard to the surgical procedure or follow-up care.
Principal Investigator: Michael Musacchio, MD
IRB Approval Number: EH15-059
Funding Source: Centinel Spine, Inc.
Contact: Please call 847.570.4046 with questions regarding the study.